BioMimetic Therapeutics, Inc. (NASDAQ:BMTI.DL)

CAPS Rating: No stars

The Company develops and commercializes bio-active drug-device combination products for the healing of musculoskeletal injuries and diseases, including periodontal, orthopedic, spine and sports injury applications.

Recs

0
Player Avatar pchop123 (76.56) Submitted: 7/8/2012 10:52:35 PM : Underperform Start Price: $2.84 BMTI.DL Score: -22.98

downside

Featured Broker Partners


Advertisement